StonvexLoading…
StonvexStonvexStonvexCore line items from DBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-07 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $632.48M | $629.50M | $2.52B | $1.88B | $1.25B |
Operating Income | Not available | $172.80M | $689.10M | $526.90M | $352.20M |
Net Income | Not available | $114.50M | $508.40M | $399.70M | $275.90M |
EPS (Diluted) | $0.75 | $0.48 | $1.86 | $1.43 | $0.96 |
Total Assets | Not available | $3.03B | $2.84B | $2.80B | $2.78B |
Total Liabilities | Not available | $5.04B | $4.64B | $4.33B | $4.08B |
Cash & Equivalents | Not available | $1.21B | $891.30M | $730.70M | $736.30M |
Free Cash Flow OCF − CapEx | Not available | $203.30M | $930.80M | $705.90M | $412.20M |
Shares Outstanding | Not available | 236.70M | 272.80M | 279.10M | 286.10M |